BSL Stock Overview
Raffles Medical Group Ltd provides integrated private healthcare services primarily in Singapore, Greater China, Vietnam, Cambodia, and Japan.
No risks detected for BSL from our risk checks.
Raffles Medical Group Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||S$1.13|
|52 Week High||S$1.58|
|52 Week Low||S$1.10|
|1 Month Change||-1.74%|
|3 Month Change||-2.59%|
|1 Year Change||-0.88%|
|3 Year Change||8.65%|
|5 Year Change||-14.39%|
|Change since IPO||624.10%|
Recent News & Updates
Raffles Medical Group (SGX:BSL) Has Some Way To Go To Become A Multi-Bagger
What trends should we look for it we want to identify stocks that can multiply in value over the long term? Amongst...
|BSL||SG Healthcare||SG Market|
Return vs Industry: BSL exceeded the SG Healthcare industry which returned -8.4% over the past year.
Return vs Market: BSL exceeded the SG Market which returned -3.4% over the past year.
|BSL Average Weekly Movement||3.1%|
|Healthcare Industry Average Movement||4.8%|
|Market Average Movement||4.9%|
|10% most volatile stocks in SG Market||11.8%|
|10% least volatile stocks in SG Market||2.3%|
Stable Share Price: BSL is less volatile than 75% of SG stocks over the past 3 months, typically moving +/- 3% a week.
Volatility Over Time: BSL's weekly volatility (3%) has been stable over the past year.
About the Company
|1976||2,700||Choon Yong Loo||https://www.rafflesmedicalgroup.com|
Raffles Medical Group Ltd provides integrated private healthcare services primarily in Singapore, Greater China, Vietnam, Cambodia, and Japan. The company operates through Healthcare Services, Hospital Services, and Investment Holdings segments. Its flagship hospital is the Raffles Hospital, a tertiary care hospital that offers cancer, children and women care, Chinese medicine, counselling, dental, dialysis, diabetes and endocrinology, ear, nose, throat, eye, fertility, heart, internal medicine, neuroscience, pain management, rehabilitation, orthopedic, skin and aesthetics, surgery, nuclear medicine, and urology services.
Raffles Medical Group Fundamentals Summary
|BSL fundamental statistics|
Is BSL overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|BSL income statement (TTM)|
|Cost of Revenue||S$530.24m|
Last Reported Earnings
Dec 31, 2021
Next Earnings Date
|Earnings per share (EPS)||0.045|
|Net Profit Margin||11.63%|
How did BSL perform over the long term?See historical performance and comparison
1.6%Current Dividend Yield
Is BSL undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 3/6
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for BSL?
Other financial metrics that can be useful for relative valuation.
|What is BSL's n/a Ratio?|
Price to Earnings Ratio vs Peers
How does BSL's PE Ratio compare to its peers?
|BSL PE Ratio vs Peers|
|Company||PE||Estimated Growth||Market Cap|
A50 Thomson Medical Group
40T ISEC Healthcare
5WA OUE Lippo Healthcare
EHG Econ Healthcare (Asia)
BSL Raffles Medical Group
Price-To-Earnings vs Peers: BSL is good value based on its Price-To-Earnings Ratio (24.9x) compared to the peer average (79.1x).
Price to Earnings Ratio vs Industry
How does BSL's PE Ratio compare vs other companies in the Asian Healthcare Industry?
Price-To-Earnings vs Industry: BSL is expensive based on its Price-To-Earnings Ratio (24.9x) compared to the SG Healthcare industry average (16x)
Price to Earnings Ratio vs Fair Ratio
What is BSL's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PE Ratio||24.9x|
|Fair PE Ratio||12x|
Price-To-Earnings vs Fair Ratio: BSL is expensive based on its Price-To-Earnings Ratio (24.9x) compared to the estimated Fair Price-To-Earnings Ratio (12x).
Share Price vs Fair Value
What is the Fair Price of BSL when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: BSL (SGD1.13) is trading below our estimate of fair value (SGD1.42)
Significantly Below Fair Value: BSL is trading below fair value by more than 20%.
Price to Earnings Growth Ratio
PEG Ratio: BSL is poor value based on its PEG Ratio (39.5x)
Discover undervalued companies
How is Raffles Medical Group forecast to perform in the next 1 to 3 years based on estimates from 9 analysts?
Future Growth Score0/6
Future Growth Score 0/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: BSL's forecast earnings growth (0.6% per year) is below the savings rate (1.8%).
Earnings vs Market: BSL's earnings (0.6% per year) are forecast to grow slower than the SG market (12.6% per year).
High Growth Earnings: BSL's earnings are forecast to grow, but not significantly.
Revenue vs Market: BSL's revenue (2.4% per year) is forecast to grow slower than the SG market (7.8% per year).
High Growth Revenue: BSL's revenue (2.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: BSL's Return on Equity is forecast to be low in 3 years time (8.3%).
Discover growth companies
How has Raffles Medical Group performed over the past 5 years?
Past Performance Score5/6
Past Performance Score 5/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: BSL has high quality earnings.
Growing Profit Margin: BSL's current net profit margins (11.6%) are higher than last year (11.6%).
Past Earnings Growth Analysis
Earnings Trend: BSL's earnings have grown by 1.7% per year over the past 5 years.
Accelerating Growth: BSL's earnings growth over the past year (27.7%) exceeds its 5-year average (1.7% per year).
Earnings vs Industry: BSL earnings growth over the past year (27.7%) exceeded the Healthcare industry 12%.
Return on Equity
High ROE: BSL's Return on Equity (8.6%) is considered low.
Discover strong past performing companies
How is Raffles Medical Group's financial position?
Financial Health Score5/6
Financial Health Score 5/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: BSL's short term assets (SGD439.1M) exceed its short term liabilities (SGD416.6M).
Long Term Liabilities: BSL's short term assets (SGD439.1M) exceed its long term liabilities (SGD152.1M).
Debt to Equity History and Analysis
Debt Level: BSL has more cash than its total debt.
Reducing Debt: BSL's debt to equity ratio has increased from 4.8% to 21.5% over the past 5 years.
Debt Coverage: BSL's debt is well covered by operating cash flow (76.1%).
Interest Coverage: BSL's interest payments on its debt are well covered by EBIT (20.7x coverage).
Discover healthy companies
What is Raffles Medical Group current dividend yield, its reliability and sustainability?
Dividend Score 3/6
Future Dividend Coverage
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: BSL's dividend (1.59%) isn’t notable compared to the bottom 25% of dividend payers in the SG market (2.34%).
High Dividend: BSL's dividend (1.59%) is low compared to the top 25% of dividend payers in the SG market (6.22%).
Stability and Growth of Payments
Stable Dividend: BSL's dividend payments have been volatile in the past 10 years.
Growing Dividend: BSL's dividend payments have increased over the past 10 years.
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (39.9%), BSL's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonably low cash payout ratio (31.1%), BSL's dividend payments are well covered by cash flows.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Choon Yong Loo (73 yo)
Dr. Choon Yong Loo co-founded Group Ltd in 1976. He served as its Non-Independent Executive Chairman at Raffles Medical Group Ltd since 1997 until January 01, 2022 and has been its Executive Chairman and E...
Experienced Management: BSL's management team is considered experienced (2.1 years average tenure).
Experienced Board: BSL's board of directors are considered experienced (4 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Raffles Medical Group Ltd's employee growth, exchange listings and data sources
- Name: Raffles Medical Group Ltd
- Ticker: BSL
- Exchange: SGX
- Founded: 1976
- Industry: Health Care Facilities
- Sector: Healthcare
- Implied Market Cap: S$2.094b
- Shares outstanding: 1.85b
- Website: https://www.rafflesmedicalgroup.com
Number of Employees
- Raffles Medical Group Ltd
- 585 North Bridge Road
- Raffles Hospital, No. 11-00
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/06/27 00:00|
|End of Day Share Price||2022/06/27 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.